CRP

C-Reactive Protein

Other

What is C-Reactive Protein?

C-reactive protein (CRP) is an acute-phase protein produced by the liver in response to inflammation anywhere in the body. Discovered in 1930 and named for its ability to bind the C-polysaccharide of Streptococcus pneumoniae, CRP is one of the most sensitive and rapidly responding markers of systemic inflammation. CRP levels can rise by 1,000-fold within 24–48 hours of an inflammatory stimulus and fall equally quickly (half-life of about 19 hours) when the stimulus resolves. This makes CRP an excellent real-time indicator of inflammatory activity.

There are two versions of the CRP test with different clinical applications. The standard CRP test measures levels across a wide range (typically 10–1,000 mg/L) and is used to detect and monitor significant inflammation from infections, autoimmune diseases, and tissue injury. The high-sensitivity CRP (hs-CRP) test measures very low levels (0.5–10 mg/L) and is used specifically for cardiovascular risk assessment, as chronic low-grade inflammation plays a central role in atherosclerosis. The JUPITER trial demonstrated that statin therapy in patients with elevated hs-CRP (but normal cholesterol) reduced cardiovascular events, underscoring CRP's importance in cardiac risk stratification.

Why It Matters

CRP is one of the most widely used and clinically versatile inflammatory markers. In acute settings, it helps diagnose and monitor infections, guide antibiotic therapy, and detect post-surgical complications. In chronic disease, it tracks disease activity in conditions like rheumatoid arthritis, inflammatory bowel disease, and lupus. For cardiovascular health, hs-CRP independently predicts heart attack, stroke, and cardiovascular death—even in people with normal cholesterol. An hs-CRP >2.0 mg/L doubles the relative risk of cardiovascular events. CRP is also increasingly recognized as a prognostic marker in cancer and COVID-19.

Normal Reference Ranges

GroupRangeUnit
Normal (standard CRP)<10mg/L
Low Cardiovascular Risk (hs-CRP)<1.0mg/L
Average Cardiovascular Risk (hs-CRP)1.0–3.0mg/L
High Cardiovascular Risk (hs-CRP)>3.0mg/L
Acute Inflammation>10mg/L
Severe Infection/Sepsis>100mg/L

Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.

What High CRP Levels Mean

Common Causes

  • Bacterial infections (CRP typically >50–100 mg/L)
  • Viral infections (CRP usually 10–40 mg/L)
  • Autoimmune diseases (rheumatoid arthritis, lupus, vasculitis)
  • Inflammatory bowel disease (Crohn's, ulcerative colitis)
  • Tissue injury or surgery
  • Obesity (adipose tissue produces inflammatory cytokines)
  • Smoking
  • Cardiovascular disease (atherosclerosis)
  • Cancer
  • Burns and trauma

Possible Symptoms

  • CRP itself causes no symptoms—it is a marker of underlying inflammation
  • Symptoms depend on the underlying cause: fever, pain, swelling, redness, fatigue
  • Chronic mild elevation may be completely asymptomatic

What to do: Interpretation depends entirely on clinical context. Markedly elevated CRP (>100 mg/L) strongly suggests bacterial infection or major tissue injury and warrants urgent evaluation. Moderate elevation (10–50 mg/L) requires workup for infection, autoimmune disease, or malignancy. For cardiovascular risk assessment, hs-CRP >2.0 mg/L measured twice (at least 2 weeks apart, in the absence of acute illness) indicates elevated risk. Statin therapy reduces both CRP and cardiovascular events. Lifestyle interventions (weight loss, exercise, smoking cessation) also lower CRP. Anti-inflammatory medications treat CRP by addressing the underlying condition.

What Low CRP Levels Mean

Common Causes

  • Normal health (absence of significant inflammation)
  • Statin therapy (reduces CRP by 15–30%)
  • Regular exercise and healthy lifestyle
  • Rarely, liver failure (impaired CRP production)

Possible Symptoms

  • Low CRP is a marker of good health and low inflammation
  • No symptoms associated with low CRP

What to do: A low CRP is generally excellent news, indicating minimal systemic inflammation. In the context of cardiovascular risk, hs-CRP <1.0 mg/L is associated with the lowest risk. No action is needed for a low CRP. If CRP is unexpectedly low in a patient who should have significant inflammation (active autoimmune disease, obvious infection), liver function should be evaluated as the liver may not be producing CRP adequately.

When Is CRP Testing Recommended?

  • When infection is suspected (to help distinguish bacterial from viral)
  • To monitor disease activity in autoimmune and inflammatory conditions
  • Cardiovascular risk assessment (hs-CRP) as part of global risk calculation
  • After surgery (to detect complications or infection)
  • When evaluating fever of unknown origin
  • To monitor response to anti-inflammatory therapy

Frequently Asked Questions

CRP and hs-CRP measure the same protein—the difference is the test's sensitivity. Standard CRP assays are designed to detect high levels associated with acute inflammation (infections, flares of autoimmune disease) and are reported in mg/L with a detection threshold around 3–10 mg/L. High-sensitivity CRP (hs-CRP) uses more sensitive assay methods to detect very low levels (0.3–10 mg/L), which are relevant for assessing chronic low-grade inflammation associated with cardiovascular disease. Your doctor orders standard CRP for acute illness and hs-CRP for heart disease risk assessment.
Yes, numerous large studies have demonstrated that hs-CRP independently predicts cardiovascular events. The Women's Health Study showed that hs-CRP was a stronger predictor of cardiovascular events than LDL cholesterol. An hs-CRP >3.0 mg/L approximately doubles cardiovascular risk compared to <1.0 mg/L. The JUPITER trial showed that statin therapy in patients with normal LDL but elevated hs-CRP (>2.0 mg/L) reduced heart attacks by 54% and strokes by 48%. However, CRP is best used as one component of comprehensive risk assessment alongside traditional risk factors.
Several lifestyle modifications effectively reduce CRP: regular exercise (30 minutes of moderate activity most days can lower CRP by 20–30%), weight loss (even 5–10% body weight reduction significantly lowers CRP), smoking cessation, a Mediterranean-style diet (rich in fruits, vegetables, fish, olive oil), adequate sleep (7–8 hours), and stress management. Specific foods like fatty fish, nuts, berries, and leafy greens have anti-inflammatory properties. Reducing refined sugars, processed foods, and trans fats also helps. If lifestyle changes are insufficient, statins and aspirin have anti-inflammatory effects beyond their primary mechanisms.
Standard CRP testing is not recommended for routine screening in healthy people—it is used when infection, inflammation, or specific disease monitoring is needed. For cardiovascular risk, the AHA/ACC guidelines suggest hs-CRP testing for individuals at intermediate cardiovascular risk (10–20% ten-year risk) to help refine risk stratification and guide treatment decisions. It is not recommended for low-risk or very high-risk individuals where it would not change management. If tested, hs-CRP should be measured twice, at least 2 weeks apart, and not during acute illness.

Related Biomarkers

WBCWhite Blood CellsALBAlbuminFerritinFerritinGLUGlucoseHbA1cHemoglobin A1cUAUric Acid

Want your CRP levels analyzed?

Upload your lab results for an instant AI-powered breakdown of all your biomarkers.

Upload Lab Results →

Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.

Disclaimer: SymptomGPT is not a medical diagnosis tool and does not provide medical advice. Always consult a qualified healthcare professional. If you are experiencing a medical emergency, call 911 immediately.